Berkshire Hathaway either initiated in Royalty Pharma in Q3 or substantially added to their $ 550M position, according to this article:
https://finance.yahoo.com/news/market-hitting-time-highs-warren-223000730.html
Royalty is second in size only to Apple in Harvard University Endowment Fund run by Harvard Management Co.
https://www.insidermonkey.com/blog/harvard-university-stock-portfolio-top-5-picks-982703/
The company will be presenting to an Evercore Health Conference Thursday morning and I'll be listening to the webcast of their presentation.